Therefore, our results indicate that RNF5 inhibition could switch EphA2 from tumor-promoting to tumor-suppressive functions by promoting its stability and cell-surface distribution, inducing the unbalance of EphA2 phosphorylation and then decreasing ERK-MAPK activation. This evidence concerns the gene EPHA2 and neoplasm.